These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8343628)

  • 1. Is screening and intervention for microalbuminuria worthwhile in patients with insulin dependent diabetes?
    Borch-Johnsen K; Wenzel H; Viberti GC; Mogensen CE
    BMJ; 1993 Jun; 306(6894):1722-5. PubMed ID: 8343628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Increased clinical and economic advantages using PROSIT (proteinuria screening and intervention) in type 2 diabetic patients].
    Gozzoli V; Palmer AJ; Brandt A; Weiss C; Piehlmeier W; Landgraf R; Renner R
    Dtsch Med Wochenschr; 2000 Sep; 125(39):1154-9. PubMed ID: 11075242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microalbuminuria in diabetes mellitus: efficacy of a new screening method in comparison with timed overnight urine collection.
    Meinhardt U; Ammann RA; Flück C; Diem P; Mullis PE
    J Diabetes Complications; 2003; 17(5):254-7. PubMed ID: 12954153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA.
    Palmer AJ; Valentine WJ; Chen R; Mehin N; Gabriel S; Bregman B; Rodby RA
    Nephrol Dial Transplant; 2008 Apr; 23(4):1216-23. PubMed ID: 18359872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy.
    Parving HH
    J Hypertens Suppl; 1998 Jan; 16(1):S99-101. PubMed ID: 9534107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-consequence analysis in a French setting of screening and optimal treatment of nephropathy in hypertensive patients with type 2 diabetes.
    Palmer AJ; Chen R; Valentine WJ; Roze S; Bregman B; Mehin N; Gabriel S
    Diabetes Metab; 2006 Feb; 32(1):69-76. PubMed ID: 16523189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diabetic kidney: from hyperfiltration and microalbuminuria to end-stage renal failure.
    Mogensen CE; Schmitz O
    Med Clin North Am; 1988 Nov; 72(6):1465-92. PubMed ID: 3054363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening to prevent renal failure in insulin dependent diabetic patients: an economic evaluation.
    Kiberd BA; Jindal KK
    BMJ; 1995 Dec; 311(7020):1595-9. PubMed ID: 8555801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can a semi-quantitative method replace the current quantitative method for the annual screening of microalbuminuria in patients with diabetes? Diagnostic accuracy and cost-saving analysis considering the potential health burden.
    Kim Y; Park S; Kim MH; Song SH; Lee WM; Kim HS; Jin K; Han S; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(1):e0227694. PubMed ID: 31961894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and health economic implications of early treatment with irbesartan of patients with type 2 diabetes mellitus, hypertension and nephropathy].
    Palmer AJ; Roze S; Rodby RA; Valentine WJ; Ritz E; Lehnert H
    Dtsch Med Wochenschr; 2006 Aug; 131(31-32):1721-6. PubMed ID: 16868875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study.
    Rossing P; Hougaard P; Borch-Johnsen K; Parving HH
    BMJ; 1996 Sep; 313(7060):779-84. PubMed ID: 8842069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microalbuminuria: a marker to increased renal and cardiovascular risk in diabetes mellitus.
    McKenna K; Thompson C
    Scott Med J; 1997 Aug; 42(4):99-104. PubMed ID: 9507584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration.
    Forsblom CM; Groop PH; Ekstrand A; Groop LC
    BMJ; 1992 Oct; 305(6861):1051-3. PubMed ID: 1467683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
    Boersma C; Gansevoort RT; Pechlivanoglou P; Visser ST; van Toly FF; de Jong-van den Berg LT; de Jong PE; Postma MJ;
    Clin Ther; 2010 Jun; 32(6):1103-21. PubMed ID: 20637965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing effects of antihypertensive agents on urinary albumin excretion.
    Weir MR
    Am J Nephrol; 1996; 16(3):237-45. PubMed ID: 8739883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of diabetic nephropathy. Microalbuminuria and perspectives for intervention in insulin-dependent diabetes.
    Mathiesen ER
    Dan Med Bull; 1993 Jun; 40(3):273-85. PubMed ID: 8339600
    [No Abstract]   [Full Text] [Related]  

  • 18. An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting.
    Palmer AJ; Annemans L; Roze S; Lamotte M; Rodby RA; Bilous RW
    J Hum Hypertens; 2004 Oct; 18(10):733-8. PubMed ID: 15116142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan reduces the burden and cost of ESRD: public health implications from the RENAAL study for the European Union.
    Gerth WC; Remuzzi G; Viberti G; Hannedouche T; Martinez-Castelao A; Shahinfar S; Carides GW; Brenner B
    Kidney Int Suppl; 2002 Dec; (82):S68-72. PubMed ID: 12410859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irbesartan treatment of patients with type 2 diabetes, hypertension and renal disease: a UK health economics analysis.
    Palmer AJ; Valentine WJ; Ray JA
    Int J Clin Pract; 2007 Oct; 61(10):1626-33. PubMed ID: 17877649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.